These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17723117)

  • 1. Neonatal immune tolerance for hemophilia: can we "tolerate" new paradigms for gene therapy trials?
    Monahan PE
    J Thromb Haemost; 2007 Sep; 5(9):1801-4. PubMed ID: 17723117
    [No Abstract]   [Full Text] [Related]  

  • 2. Induced immunotolerance in factor VIII inhibitor patients.
    Brackmann HH
    Prog Clin Biol Res; 1984; 150():181-95. PubMed ID: 6431426
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor VIII-specific memory B cells in patients with hemophilia A.
    van Helden PM; Kaijen PH; Fijnvandraat K; van den Berg HM; Voorberg J
    J Thromb Haemost; 2007 Nov; 5(11):2306-8. PubMed ID: 17958750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemophilia A with factor VIII inhibitor].
    Shima M
    Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A.
    Cai Y; Shi Q
    Front Immunol; 2020; 11():964. PubMed ID: 32595633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.
    Chen Y; Luo X; Schroeder JA; Chen J; Baumgartner CK; Hu J; Shi Q
    J Thromb Haemost; 2017 Oct; 15(10):1994-2004. PubMed ID: 28799202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A.
    Samelson-Jones BJ; Arruda VR
    Front Immunol; 2020; 11():618. PubMed ID: 32425925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New technologies in gene therapy for inducing immune tolerance in hemophilia A.
    Borsotti C; Follenzi A
    Expert Rev Clin Immunol; 2018 Dec; 14(12):1013-1019. PubMed ID: 30345839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin.
    Biswas M; Palaschak B; Kumar SRP; Rana J; Markusic DM
    Front Immunol; 2020; 11():1293. PubMed ID: 32670285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
    Berntorp E; Astermark J; Carlborg E
    Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy.
    Chen AC; Cai X; Li C; Khoryati L; Gavin MA; Miao CH
    Front Immunol; 2020; 11():638. PubMed ID: 32411127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice.
    Peng B; Ye P; Blazar BR; Freeman GJ; Rawlings DJ; Ochs HD; Miao CH
    Blood; 2008 Sep; 112(5):1662-72. PubMed ID: 18574023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression reduces an antibody response after neonatal gene therapy with B domain-deleted human factor VIII in mice.
    Xu L; Mei M; Ma X; Ponder KP
    J Thromb Haemost; 2007 Sep; 5(9):1805-12. PubMed ID: 17596134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.
    Chen J; Schroeder JA; Luo X; Montgomery RR; Shi Q
    J Thromb Haemost; 2019 Mar; 17(3):449-459. PubMed ID: 30609275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy.
    Sack BK; Merchant S; Markusic DM; Nathwani AC; Davidoff AM; Byrne BJ; Herzog RW
    PLoS One; 2012; 7(5):e37671. PubMed ID: 22655063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral treatment of haemophilia a by factor VIII bound to chylomicra.
    Paulssen MM; van Pelt BC
    Lancet; 1981 Jun; 1(8233):1310. PubMed ID: 6112618
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy for immune tolerance induction in hemophilia with inhibitors.
    Arruda VR; Samelson-Jones BJ
    J Thromb Haemost; 2016 Jun; 14(6):1121-34. PubMed ID: 27061380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    Fu RY; Chen AC; Lyle MJ; Chen CY; Liu CL; Miao CH
    Cell Immunol; 2020 Dec; 358():104216. PubMed ID: 32987195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII inhibitors revisited.
    Bloom AL
    Br J Haematol; 1981 Nov; 49(3):319-24. PubMed ID: 6794594
    [No Abstract]   [Full Text] [Related]  

  • 20. Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapies.
    Nichols TC; Hough C; Agersø H; Ezban M; Lillicrap D
    J Thromb Haemost; 2016 May; 14(5):894-905. PubMed ID: 26924758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.